Drug Discovery Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:May 2021
  • Pages:90
  • Formats:
  • Report Code:40443

Report Summary

Eternity Insights has published a new study on Global Drug Discovery Market focusing on key segments as by Type (Small Molecule Drug, Biologics Drug, Other), by Application (Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Drug Discovery Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Drug Discovery Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Drug Discovery Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Drug Discovery Market Segmentation:

Drug Discovery Market, By Type

  • Small Molecule Drug
  • Biologics Drug
  • Other

Drug Discovery Market, By Application

  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Drug Discovery market in terms of demand generation. The Drug Discovery market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Drug Discovery market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Drug Discovery Market Taxonomy:

To learn more about this report

Request For Sample

Global Drug Discovery Market Competitive Landscape

The global Drug Discovery market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

  • Company Overview
  • Financial Analysis
  • Product Portfolio Analysis
  • Strategic Overview
  • SWOT Analysis

List of Companies Profiled in the report:

  • Pfizer
  • GSK
  • Merck
  • Agilent
  • Eli Lilly and Company
  • Roche
  • Bayer
  • Abbott
  • AstraZeneca
  • Shimadzu
  • Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Small Molecule Drug, Biologics Drug, Other
By Application Outlook Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Pfizer, GSK, Merck, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Discovery Market Size Growth Rate by Type (2014-2025)
1.4.2 Small Molecule Drug
1.4.3 Biologics Drug
1.5 Market by Application
1.5.1 Global Drug Discovery Market Share by Application (2014-2025)
1.5.2 Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Drug Discovery Market Size
2.2 Drug Discovery Growth Trends by Regions
2.2.1 Drug Discovery Market Size by Regions (2014-2025)
2.2.2 Drug Discovery Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Drug Discovery Market Size by Manufacturers
3.1.1 Global Drug Discovery Revenue by Manufacturers (2017-2020)
3.1.2 Global Drug Discovery Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.2 Drug Discovery Key Players Head office and Area Served
3.3 Key Players Drug Discovery Product/Solution/Service
3.4 Date of Enter into Drug Discovery Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Drug Discovery Market Size by Type (2017-2020)
4.2 Global Drug Discovery Market Size by Application (2017-2020)

5 United States
5.1 United States Drug Discovery Market Size (2017-2020)
5.2 Drug Discovery Key Players in United States
5.3 United States Drug Discovery Market Size by Type
5.4 United States Drug Discovery Market Size by Application

6 Europe
6.1 Europe Drug Discovery Market Size (2017-2020)
6.2 Drug Discovery Key Players in Europe
6.3 Europe Drug Discovery Market Size by Type
6.4 Europe Drug Discovery Market Size by Application

7 China
7.1 China Drug Discovery Market Size (2017-2020)
7.2 Drug Discovery Key Players in China
7.3 China Drug Discovery Market Size by Type
7.4 China Drug Discovery Market Size by Application

8 Japan
8.1 Japan Drug Discovery Market Size (2017-2020)
8.2 Drug Discovery Key Players in Japan
8.3 Japan Drug Discovery Market Size by Type
8.4 Japan Drug Discovery Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Drug Discovery Market Size (2017-2020)
9.2 Drug Discovery Key Players in Southeast Asia
9.3 Southeast Asia Drug Discovery Market Size by Type
9.4 Southeast Asia Drug Discovery Market Size by Application

10 India
10.1 India Drug Discovery Market Size (2017-2020)
10.2 Drug Discovery Key Players in India
10.3 India Drug Discovery Market Size by Type
10.4 India Drug Discovery Market Size by Application

11 Central & South America
11.1 Central & South America Drug Discovery Market Size (2017-2020)
11.2 Drug Discovery Key Players in Central & South America
11.3 Central & South America Drug Discovery Market Size by Type
11.4 Central & South America Drug Discovery Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Discovery Introduction
12.1.4 Pfizer Revenue in Drug Discovery Business (2017-2020)
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Discovery Introduction
12.2.4 GSK Revenue in Drug Discovery Business (2017-2020)
12.2.5 GSK Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Discovery Introduction
12.3.4 Merck Revenue in Drug Discovery Business (2017-2020)
12.3.5 Merck Recent Development
12.4 Agilent
12.4.1 Agilent Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Discovery Introduction
12.4.4 Agilent Revenue in Drug Discovery Business (2017-2020)
12.4.5 Agilent Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Discovery Introduction
12.5.4 Eli Lilly and Company Revenue in Drug Discovery Business (2017-2020)
12.5.5 Eli Lilly and Company Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Discovery Introduction
12.6.4 Roche Revenue in Drug Discovery Business (2017-2020)
12.6.5 Roche Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Discovery Introduction
12.7.4 Bayer Revenue in Drug Discovery Business (2017-2020)
12.7.5 Bayer Recent Development
12.8 Abbott
12.8.1 Abbott Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Discovery Introduction
12.8.4 Abbott Revenue in Drug Discovery Business (2017-2020)
12.8.5 Abbott Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Discovery Introduction
12.9.4 AstraZeneca Revenue in Drug Discovery Business (2017-2020)
12.9.5 AstraZeneca Recent Development
12.10 Shimadzu
12.10.1 Shimadzu Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Discovery Introduction
12.10.4 Shimadzu Revenue in Drug Discovery Business (2017-2020)
12.10.5 Shimadzu Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

close

categories